Feedback / Questions
ENA101 - Enara Bio
https://www.globenewswire.com/news-release/2025/11/04/3180455/0/en/Enara-Bio-s-DARKFOX-Discovery-Propels-ENA101-the-First-Ever-Bispecific-T-Cell-Engager-Targeting-a-Cancer-Specific-Dark-Antigen-into-IND-Enabling-Studies.html
Nov 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next